P1129 EFFECT OF HCV GENOTYPE-1 SUBTYPE ON RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: POOLED DATA FROM PHASE III TRIALS

2014 ◽  
Vol 60 (1) ◽  
pp. S457
Author(s):  
I.M. Jacobson ◽  
D.M. Jensen ◽  
D. Dieterich ◽  
C. Sarrazin ◽  
G.R. Foster ◽  
...  
Keyword(s):  
Pegylated Interferon ◽  
Phase Iii ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Pooled Data ◽  
Phase Iii Trials ◽  
Treatment Naïve ◽  
Hcv Genotype 1

Su1056 Effect of HCV Genotype-1 Subtype on Response to Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Treatment-Naïve Patients: Pooled Data From Phase III Trials

2014 ◽  
Vol 146 (5) ◽  
pp. S-976
Author(s):  
Ira M. Jacobson ◽  
Donald M. Jensen ◽  
Douglas T. Dieterich ◽  
Christoph Sarrazin ◽  
Graham Foster ◽  
...  
Keyword(s):  
Pegylated Interferon ◽  
Phase Iii ◽  
Interferon Α ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Pooled Data ◽  
Phase Iii Trials ◽  
Treatment Naïve ◽  
Hcv Genotype 1

scholarly journals Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials

2016 ◽  
Vol 15 (3) ◽  
pp. 333-349 ◽  
Author(s):  
Donald M. Jensen ◽  
Tarik Asselah ◽  
Douglas Dieterich ◽  
Graham R. Foster ◽  
Mark S. Sulkowski ◽  
...  
Keyword(s):  
Pegylated Interferon ◽  
Pooled Analysis ◽  
Genotype 1 ◽  
Phase 3 ◽  
Two Phase ◽  
Hcv Genotype ◽  
Treatment Naïve ◽  
Hcv Genotype 1
Sign in / Sign up

Export Citation Format

Share Document